MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jad.2026.122588

Медицинская библиотека · Journal of affective disorders · 2026

Cannabis use and subsequent onset of manic symptoms and bipolar disorder: A systematic review and meta-analysis.

Sanjuan-Ortiz Cecilia, Querol Paula, Aymerich Claudia, Laherran Nuria, Ditlevsen Fanny, Navalón Pablo, Rojo-Bofill Luis M, Young Allan H, Arango Celso, Sharma Aditya, Di Forti Marta, Murray Robin M, Correll Christoph U, de Pablo Gonzalo Salazar

СтатьяОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND

Bipolar disorder is a disabling psychiatric condition affecting approximately 2% of the population, for which identifying modifiable risk factors prior to illness onset is a research priority. Cannabis use is highly prevalent, yet its role in the development of bipolar-spectrum outcomes remains unclear. Previous reviews have included few studies or combined distinct bipolar-spectrum outcomes, limiting outcome-specific inference.

AIMS: To evaluate the association between cannabis exposure and subsequent incident BD and manic/hypomanic symptoms separately and examine potential moderating factors.

METHODS

Registered (https://osf.io/s38x4/), PRISMA/MOOSE-compliant systematic review and meta-analysis of PubMed and Web of Science from inception to October 2025. We included longitudinal observational studies comparing cannabis-exposed and unexposed individuals without prior BD and assessing subsequent bipolar-spectrum outcomes. We meta-analysed studies with extractable data, calculating the unadjusted risk ratios (RRs) for incident BD and manic/hypomanic symptoms. Random-effects meta-analyses, heterogeneity analyses, subgroup analyses and meta-regressions were performed. Study quality was appraised using the Newcastle-Ottawa Scale (NOS).

RESULTS

Nineteen studies were included (total N = 6,960,517; mean age 23.8 ± 11.8 years; 49% female). Cannabis use was associated with increased risk of BD (RR = 2.46, 95% CI = 1.57-3.84; k = 8; N = 206.572) and manic/hypomanic symptoms (RR = 2.11, 95% CI = 1.07-4.18; k = 6; N = 57,243). Moderator analyses identified significant clinical and methodological sources of heterogeneity. NOS scores ranged from 6 to 9, indicating good to high methodological quality.

CONCLUSION

Cannabis use was associated with an increased risk of subsequent bipolar-spectrum outcomes. Routine evaluation of cannabis use alongside prevention strategies, to delay initiation and reduce use, may warranted.

Для цитирования: Sanjuan-Ortiz Cecilia, Querol Paula, Aymerich Claudia, Laherran Nuria, Ditlevsen Fanny, Navalón Pablo, Rojo-Bofill Luis M, Young Allan H, Arango Celso, Sharma Aditya, Di Forti Marta, Murray Robin M, Correll Christoph U, de Pablo Gonzalo Salazar. Cannabis use and subsequent onset of manic symptoms and bipolar disorder: A systematic review and meta-analysis.. Journal of affective disorders. 2026. DOI: 10.1016/j.jad.2026.122588.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.